Turn Therapeutics Inc.（TTRX）内部人交易：高管与董事近期交易
过去 18 个月，共有 9 位内部人为 Turn Therapeutics Inc.（TTRX）报告了 25 笔 Form 4 交易（最近一笔 2026-06-01）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-01 | BEB Holdings, LLC | 10% 以上股东 | 卖出 | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | 卖出 | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% 以上股东 | 买入 | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | 买入 | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% 以上股东 | 卖出 | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | 卖出 | 300,000 | $0 |
| 2026-06-01 | BEB Holdings, LLC | 10% 以上股东 | 买入 | 300,000 | $0 |
| 2026-06-01 | Burnam Bradley Evan | Chief Executive Officer | 买入 | 300,000 | $0 |
| 2026-04-03 | BEB Holdings, LLC | 10% 以上股东 | 卖出 | 300,000 | $0 |
| 2026-04-03 | Burnam Bradley Evan | Chief Executive Officer | 卖出 | 300,000 | $0 |
| 2026-04-03 | GOLDEN ARTHUR F | 董事 | 买入 | 300,000 | $0 |
| 2026-02-04 | Dewhurst Martin William | 董事 | 买入 | 21,882 | $0 |
| 2025-12-12 | Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer | 买入 | 2,500 | $8,750 |
| 2025-11-25 | GOLDEN ARTHUR F | 董事 | 买入 | 9,868 | $33,946 |
| 2025-11-24 | GOLDEN ARTHUR F | 董事 | 买入 | 20,532 | $58,927 |
| 2025-11-21 | Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer | 买入 | 1,450 | $3,784 |
| 2025-11-21 | Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer | 买入 | 1,000 | $3,290 |
| 2025-11-17 | Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer | 买入 | 2,500 | $9,050 |
| 2025-10-29 | Chesed Abraham | 内部人 | 买入 | 14,286 | $65,716 |
| 2025-10-23 | GOLDEN ARTHUR F | 董事 | 买入 | 20,202 | $100,000 |
| 2025-10-23 | Chaudhary Zuraiz | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer | 买入 | 5,050 | $24,998 |
| 2025-10-10 | Kester Kent Edward | 董事 | 买入 | 10,000 | $0 |
| 2025-10-10 | Gengos Andrew | 董事 | 买入 | 10,000 | $0 |
| 2025-10-10 | Ghodadra Neilesh Shailesh | Chief Medical Officer | 买入 | 10,000 | $0 |
| 2025-10-10 | GOLDEN ARTHUR F | 董事 | 买入 | 10,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-01